What are the types of cryoglobulinemic glomerulonephritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Types of Cryoglobulinemic Glomerulonephritis

Cryoglobulinemic glomerulonephritis is classified into two main types based on the immunoglobulin composition: Type I (monoclonal) and Type II/III (mixed cryoglobulinemia), with only Type I and II cryoglobulinemias considered associated with monoclonal immunoglobulins and causing renal disease. 1

Classification by Cryoglobulin Type

Type I Cryoglobulinemia

  • Contains monoclonal immunoglobulin only (typically IgM or IgG) 2
  • Associated with lymphoproliferative disorders such as multiple myeloma, Waldenström macroglobulinemia, or B-cell lymphomas 2
  • Characterized by immunoglobulin thrombi in arterioles and glomerular capillaries that exhibit crystalline structure or periodicity on electron microscopy 1
  • Can present with intravascular cryoglobulin thrombi or endovasculitis affecting blood vessels 1

Type II Mixed Cryoglobulinemia (Most Common Renal Type)

  • Composed of monoclonal IgM (usually IgMκ) acting as rheumatoid factor bound to polyclonal IgG 3
  • Accounts for 74.4% of cryoglobulinemic glomerulonephritis cases 4
  • Strongly associated with hepatitis C virus infection (87% of cases) 4
  • The monoclonal IgM component specifically targets the polyclonal IgG, forming immune complexes 3

Type III Mixed Cryoglobulinemia

  • Contains polyclonal IgM bound to polyclonal IgG 2, 3
  • Less commonly causes glomerulonephritis compared to Type II 4
  • Also associated with HCV infection and autoimmune diseases 2

Histopathologic Classification

Membranoproliferative Pattern (Most Common)

  • Diffuse membranoproliferative glomerulonephritis occurs in approximately 80-83% of cases 1, 4
  • Characterized by large deposits filling capillary lumens with fibrillar or crystalloid structure on electron microscopy 3
  • Massive monocyte infiltration creates prominent exudative component 3
  • Double-contoured glomerular basement membrane appearance due to peripheral monocyte interposition 3

Crystalline Variant (Cryocrystalglobulinemic Glomerulonephritis)

  • Rare variant characterized by immunoglobulin thrombi with crystalline structure in arterioles and glomerular capillaries 1
  • Exhibits crystalline structure or periodicity on electron microscopy 1
  • Crystallization in periphery can be precipitated by cold exposure, resulting in small-vessel occlusion and thrombosis 1

Crescentic/Rapidly Progressive Pattern

  • Can present as rapidly progressive glomerulonephritis with crescent formation 5
  • Immune complex-type RPGN with granular deposits of IgA, IgG, and C3 5
  • Occluding protein thrombi in glomerular capillary loops 5

Ultrastructural Features

Microtubular Deposits

  • Cryoglobulinemic glomerulonephritis features microtubular immunoglobulin deposits with hollow centers 1
  • Microtubules have large diameters ranging from 17-52 nm, distinguishing them from fibrils 1
  • Organized in parallel arrays visible on electron microscopy 1

Anatomic Distribution

  • Lesions mainly involve glomeruli but can occasionally affect blood vessels 1
  • Intravascular cryoglobulin thrombi or endovasculitis may be present 1
  • Subendothelial deposits predominate in immune complex deposition 5

Clinical Presentation Patterns

Acute Nephritic Syndrome (15%)

  • Characterized by acute onset with hematuria and renal impairment 1
  • Massive monocyte infiltration distinguishes it from idiopathic MPGN 3

Nephrotic Syndrome (20%)

  • Proteinuria >3 g/24h with edema and hypoalbuminemia 1
  • Some patients show mixed nephrotic and nephritic features 1

Isolated Proteinuria with Microscopic Hematuria (30%)

  • Most common presentation with proteinuria <3 g/24h 1
  • Usually accompanied by microscopic hematuria 1

Acute Renal Failure (10%)

  • Rapid decline in kidney function, sometimes with oligoanuria (5%) 1
  • May require plasmapheresis and immunosuppression 5

Important Clinical Caveats

  • Type I and II are the only cryoglobulin types considered associated with monoclonal immunoglobulins in the context of MGRS (Monoclonal Gammopathy of Renal Significance) 1
  • HCV genotype 1b is more frequent than genotype 2 (55% vs 43%) in cryoglobulinemic glomerulonephritis 4
  • Age, serum creatinine level, and proteinuria at onset independently predict risk for severe renal failure 4
  • Cardiovascular disease accounts for >60% of deaths, reflecting improved survival with modern therapies 4
  • Renal biopsy is mandatory in any patient with urinary abnormalities or unexplained renal impairment to determine histologic pattern and guide therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

New insights in cryoglobulinemic vasculitis.

Journal of autoimmunity, 2019

Research

Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1995

Research

Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.